Agilent and Picometrics agree co-marketing deal

Agilent Technologies has formed a new co-marketing agreement with Picometrics Technologies, strengthening both companies' offerings in the field of biopharmaceuticals.

The firms will be providing customers in this sector combined solutions for capillary electrophoresis (CE), laser-induced fluorescence (LIF) detection and mass spectrometry. This collection of tools represents the only online CE-LIF-MS solution available on the market.

Ideally suited for the research and development of complex large-molecule biopharmaceutical compounds, the platform will help to increase efficiency for biotherapeutic characterisation in research, development and quality control.

Several Agilent products can be combined with Picometrics' Zetalif LED and Zetalif Laser instruments, including its Capillary Electrophoresis and CE/MS technologies, as well as its HPLC/UHPLC solution.

Michael Frank, Agilent's marketing director for liquid phase separations, said: "As conventional drug research becomes outmoded in meeting the increasing demands of complex, large-molecule drug development, scientists need highly sophisticated tools like these to advance therapeutic discovery."

Earlier this month, Agilent announced that its new electronic measurement spin-off company – which will be created when the business splits in two later this year – will be called Keysight Technologies and led by Ron Nersesian.